<DOC>
	<DOCNO>NCT02203227</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety dietary supplement ( BioTurmin , BioTurmin-WD MaQxan ) cotinine level oxidative stress marker chronic smoker mild moderate hyperlipidemia 30 60 day intervention .</brief_summary>
	<brief_title>Efficacy Safety Study Dietary Supplements Chronic Smokers Having Mild Moderate Hyperlipidemia</brief_title>
	<detailed_description>In randomize , double-blind , placebo control trial , efficacy safety dietary supplement ( BioTurmin , BioTurmin-WD MaQxan ) investigate chronic smoker mild moderate hyperlipidemia . Sixty subject randomly assign receive dietary supplement placebo 60 day . The efficacy supplement measure estimate cotinine malondialdehyde level .</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Turmeric extract</mesh_term>
	<criteria>Men &gt; 20 year Chronic cigarette/ beedi smoker ( 23 packets/day since last 3 year ) mild moderate hyperlipidemia ( LDL range 160189 mg/dL , TC &gt; 200 mg/dL and/or HDLC &lt; 40 mg/dL ) Being mentally competent able understand study requirement sign inform consent form . Patients Chronic obstructive pulmonary disease ( COPD ) Women Patients severe liver , renal , cardiac brain disease . Unable complete follow . Subjects medication like diuretic . Allergic medication . With history alcohol and/or drug abuse .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Dietary supplement</keyword>
	<keyword>Cotinine level</keyword>
	<keyword>Malondialdehyde</keyword>
	<keyword>Chronic smoker</keyword>
	<keyword>Hyperlipidemia</keyword>
</DOC>